Ticker
ABOSCompany Name
ACUMEN PHARMACEUTICALS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Free Cash Flow | Free Cash Flow Yield | Market Capitalization |
---|---|---|---|
6/30/2025 | $ -117.85M | -154.41% | $ 76.32M |
3/31/2025 | $ -102.56M | -161.25% | $ 63.6M |
12/31/2024 | $ -86.23M | -115.74% | $ 74.51M |
9/30/2024 | $ -67.34M | -41.9% | $ 160.71M |
6/30/2024 | $ -55.66M | -33.44% | $ 166.42M |
3/31/2024 | $ -50.78M | -22.9% | $ 221.69M |
12/31/2023 | $ -43.08M | -19.12% | $ 225.3M |
9/30/2023 | $ -45.99M | -39.12% | $ 117.56M |
6/30/2023 | $ -42.35M | -10.45% | $ 405.08M |
3/31/2023 | $ -37.18M | -15.82% | $ 235.07M |
FCF / Market Cap
(=) FCF Yield
FCF Yield for ACUMEN PHARMACEUTICALS INC is calculated as follows: FCF [ $ 0 ] / Market Cap [ $ 618.76M ]
(=) FCF Yield [ 0% ]
Minimum
Mar 31, 2025
Maximum
Dec 31, 2021
Average
Median
filtered constituents | 3.58K |
---|---|
min | -33.87% |
max | 37.55% |
average | 1.62% |
median | 3.25% |
std | 11.36% |